Pharmaceutical Affairs Act Article 40-1

For the public benefit, the central competent health authority may, if necessary, publicize the active pharmaceutical ingredients, package inserts, or relevant information that are submitted by pharmaceutical firms in their applications for the manufacture or import of medicaments and thus held and kept by the central competent health authority. However, for information that is considered trade secrets in the new drug registration applications, the central competent health authority shall keep it confidential.The central competent health authority shall enact measures governing the extent and method of the publication authorized by the preceding paragraph.
中文原文 藥事法第40-1條
中央衛生主管機關為維護公益之目的,於必要時,得公開所持有及保管藥商申請製造或輸入藥物所檢附之藥物成分、仿單等相關資料。
但對於藥商申請新藥查驗登記屬於營業秘密之資料,應保密之。
前項得公開事項之範圍及方式,其辦法由中央衛生主管機關定之。

English translation for reference only; the Chinese text prevails. Not legal advice.